Industry    (USD)
Annual
FISCAL YEAR ENDING older 31-DEC
2004
31-DEC
2005
31-DEC
2006
31-DEC
2007
31-DEC
2008
newer
Operating Income 315M 6.50B 8.22B 8.09B 9.14B
Gross Profit 17.5B 19.9B 22.3B 25.0B 27.6B
Total Revenues 21.4B 23.9B 26.5B 29.6B 31.6B
Net Income 4.77B 6.67B 8.54B 7.98B 8.68B
Gross Margin 75.8% 77.6% 79% 78.3% 79.1%
Research and Development Expense 3.47B 3.38B 3.90B 5.16B 5.18B
R&D/Sales Ratio 16.2% 14.1% 14.7% 17.5% 16.4%
Number of Patents 0 0 0 0 0
Number of Drugs in Phase I 0 17.0 23.0 41.0 34.0
Number of Drugs in Phase II 0 15.0 20.0 20.0 31.0
Number of Drugs in Phase III 0 29.0 28.0 10.0 10.0
Number of Drug Recalls 0 0 21.0 39.0 12.0
New Drug Applications 0 25.0 21.0 0 0
Revenue - Japan 0 0 1.43B 1.58B 1.86B
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki